CD73 (NT5E) is a key ectoenzyme that hydrolyzes extracellular AMP to adenosine, modulating purinergic signaling in cardiovascular and immune microenvironments. This recombinant human construct spans residues 27–547, expressed in mammalian cells with a C-terminal 6xHis tag positioned to preserve the catalytic domain's accessibility for substrate engagement. Functional validation confirms binding activity via ELISA, where immobilized CD73-His at 2 μg/ml binds anti-human CD73 mAb with an ED50 of 3.33 ng/ml, supporting its use as a positive control in enzyme-linked assays, inhibitor screening for IC50 determination, and antibody characterization studies. Purity exceeding 95% by SDS-PAGE combined with endotoxin levels below 1.0 EU/μg satisfies the criteria typical for accurate kinetic parameter analysis (Km, Vmax, kcat) and substrate specificity profiling where contaminant phosphatases would otherwise confound enzymatic readouts.
Email: support@cusabio.com
Distributors Worldwide